James Loerop
2019
In 2019, James Loerop earned a total compensation of $1.5M as EVP, Business Development and Strategic Planning at Anika Therapeutics.
Compensation breakdown
| Bonus | $202,500 |
|---|---|
| Option Awards | $377,772 |
| Salary | $165,865 |
| Stock Awards | $732,060 |
| Other | $1,429 |
| Total | $1,479,626 |
Loerop received $732.1K in stock awards, accounting for 49% of the total pay in 2019.
Loerop also received $202.5K in bonus, $377.8K in option awards, $165.9K in salary and $1.4K in other compensation.
Rankings
In 2019, James Loerop's compensation ranked 7,373rd out of 13,971 executives tracked by ExecPay. In other words, Loerop earned more than 47.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,373 out of 13,971 | 47th |
Division Manufacturing | 2,849 out of 5,698 | 50th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 366 out of 832 | 56th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 211 out of 535 | 61st |
Industry Surgical and Medical Instruments and Apparatus | 128 out of 350 | 63rd |
Source: SEC filing on April 27, 2022.
Loerop's colleagues
We found one more compensation record of an executive who worked with James Loerop at Anika Therapeutics in 2019.
2019
Thomas Finnerty
Anika Therapeutics